[Physiopathology, diagnosis and treatment of chronic myeloproliferative diseases: discussion].
Noriko
N
Usui
Koichi
K
Miyamura
Ayako
A
Arai
Sayuri
S
Motomura
Masahiro
M
Yokoyama
D001549:Benzamides; D002908:Chronic Disease; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D010879:Piperazines / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000175:diagnosis; D055728:Primary Myelofibrosis / Q000628:therapy; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate